Drugs with this side effect as MedDRA Preferred Term
- 5-ASA
- Estrofem
- Glat copolymer
- ICI 182,780
- L-Dmp
- LY146032
- Vaginal moniliasis: 0% - 1.7%
- Meropenem anhydrous
- Oestrogen
- Vaginal moniliasis: uncommon, 4% - 8%
- TR-700
- Vulvovaginal mycotic infection
- amoxicillin
- Vaginal moniliasis
- Vulvovaginal mycotic infection: 1.99% - 2.61%
- aripiprazole
- Vaginal moniliasis
- Vaginal mycosis
- aztreonam
- bupropion
- canagliflozin
- Vulvovaginal mycotic infection
- cefaclor
- cefdinir
- cefditoren
- cefepime
- cefotetan
- cefoxitin
- ceftobiprole
- Vulvovaginal mycotic infection
- cefuroxime
- Vaginal moniliasis: postmarketing
- cefuroxime axetil
- ciprofloxacin
- Vaginal moniliasis: postmarketing, 1% - 2%
- citalopram
- Vaginal moniliasis: infrequent, uncommon
- Vulvovaginal mycotic infection: infrequent
- clarithromycin
- clindamycin
- Vaginal moniliasis: 1.5% - 13.3%
- clindamycin phosphate
- conjugated estrogens
- Vaginal moniliasis: postmarketing, 0% - 1.4%
- copolymer 1
- dalbavancin
- Vulvovaginal mycotic infection
- dapagliflozin
- Vulvovaginal mycotic infection
- delavirdine
- deprenyl
- Vaginal moniliasis: infrequent
- doxorubicin
- doxycycline
- Vaginal moniliasis
- Vulvovaginal mycotic infection: 2.03%
- doxycycline hyclate
- empagliflozin
- ertapenem
- estradiol
- Vaginal moniliasis: postmarketing, 6.19% - 10.7%
- Vaginal mycosis: 0.82% - 6.4%
- Vulvovaginal mycotic infection: 8.29%
- estradiol cypionate
- estradiol valerate
- estrone
- fenofibrate
- fluticasone furoate
- fosphenytoin
- Vaginal moniliasis: infrequent
- gabapentin
- Vaginal moniliasis: infrequent
- lamotrigine
- Vaginal moniliasis: rare, infrequent
- lasofoxifene
- leflunomide
- levonorgestrel
- linezolid
- Vaginal moniliasis: 0.4% - 1.8%
- lomefloxacin
- medroxyprogesterone
- medroxyprogesterone acetate
- meropenem
- metronidazole
- Vaginal moniliasis
- Vaginal mycosis: 0.18% - 1.06%
- moxifloxacin
- Vaginal moniliasis
- Vulvovaginal mycotic infection
- mycophenolate mofetil
- norfloxacin
- Vaginal moniliasis: postmarketing
- ofloxacin
- Vaginal moniliasis: postmarketing
- ogen
- paroxetine
- Vaginal moniliasis: rare, infrequent, 1%
- phenytoin
- Vaginal moniliasis: infrequent
- pilocarpine
- pramipexole
- pregabalin
- Vaginal moniliasis: infrequent
- progesterone
- quetiapine
- Vaginal moniliasis: infrequent
- rasagiline
- Vaginal moniliasis: infrequent
- riluzole
- ropinirole
- Vaginal moniliasis: infrequent
- Vaginal mycosis: infrequent
- salbutamol
- sitaxsentan
- sparfloxacin
- Vaginal moniliasis: postmarketing, 2.8%
- tacrolimus
- telithromycin
- tibolone
- Vaginal moniliasis
- Vaginal mycosis
- tigecycline
- tizanidine
- Vaginal moniliasis: infrequent
|